Guest: Lajos Pusztai, MD <br>

  Host: Lee Freedman, MD <br>


  
    <p>What does microarray-based gene expression profiling tell us in terms of diagnosing and treating breast cancer? How is this technology changing our perceptions of breast cancer? Dr. Lajos Pusztai, associate professor of medicine at the University of Texas M.D. Anderson Cancer Center, discusses some clinical applications of a multigene assay. Dr. Lee Freedman hosts.</p>

Guest: Lajos Pusztai, MD Host: Lee Freedman, MD What does microarray-based gene expression profiling tell us in terms of diagnosing and treating breast cancer? How is this technology changing our perceptions of breast cancer? Dr. Lajos Pusztai, associate professor of medicine at the University of Texas M.D. Anderson Cancer Center, discusses some clinical applications of a multigene assay. Dr. Lee Freedman hosts.

Exploring the Molecular Origins of Breast Cancer

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

Share Exploring the Molecular Origins of Breast Cancer

Sign up to save your podcasts

Exploring the Molecular Origins of Breast Cancer

Exploring the Molecular Origins of Breast Cancer